Evaxion Biotech
在场
Evaxion Biotech 是一家在股票代码 EVAX (DK) 下上市的公司。
高管
查看带有其 9 名主要高管的组织结构图
Evaxion Biotech 搜索最多的简介
- Christian Kanstrup, Chief Executive Officer
- Marianne Søgaard, Chairman of the Board
- Steve Projan, Board Member
创建提醒
跟踪 Evaxion Biotech 的高管变动
生物技术
Evaxion Biotech 拥有 2,317 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Evommune 刚刚宣布为 115 筹款数百万美元。 (公布2024十一月4号).
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
生物技术 行业的其他推荐联系人
消息
Evaxion Biotech 的最新新闻稿
- Strong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trials | Evaxion Biotech
- Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology™ platform | Evaxion Biotech
- Evaxion significantly expands vaccine development collaboration with MSD | Evaxion Biotech
- Evaxion launches improved AI-Immunology™ platform for vaccine antigen prediction | Evaxion Biotech
- Evaxion reports convincing one-year data from phase 2 trial on AI-designed personalized cancer vaccine EVX-01 | Evaxion Biotech
- Evaxion reports 69% Overall Response Rate in its phase 2 trial on lead cancer vaccine candidate EVX-01 | Evaxion Biotech
- Evaxion obtains pre-clinical Proof-of-Concept for mRNA Gonorrhea vaccine candidate EVX-B2 | Evaxion Biotech
- Evaxion to Present One-Year Clinical Efficacy Data from its Phase 2 Study on Lead Cancer Vaccine Candidate, EVX-01, at the ESMO Congress 2024 in September | Evaxion Biotech
- Evaxion to Announce Business Update and Second Quarter 2024 Financial Results on August 14 | Evaxion Biotech
- Evaxion Announces Business Update and Second Quarter 2024 Financial Results | Evaxion Biotech
- View more press releases Close
关于 Evaxion Biotech 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Birgitte Rønø 
